Response to letter: 'Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for SGLT-2 inhibitors?'

被引：0
|
作者：
Cunha, Filipe M. [1 ]
Bettencourt, Paulo [2 ,3 ]
Lourenco, Patricia [3 ,4 ,5 ]
机构：
[1] Ctr Hosp Tamega & Sousa, Dept Endocrinol, Ave Hosp Padre Amer 210, P-4564007 Guilhufe, Penafiel, Portugal
[2] Hosp CUF Porto, Dept Internal Med, Porto, Portugal
[3] Univ Porto, Fac Med, Porto, Portugal
[4] Ctr Hosp & Univ Sao Joao, Dept Internal Med, Porto, Portugal
[5] Ctr Hosp & Univ Sao Joao, Dept Internal Med, Heart Failure Clin, Porto, Portugal
来源：
JOURNAL OF CARDIOVASCULAR MEDICINE | 2020年 / 21卷 / 04期
关键词：
D O I：
10.2459/JCM.0000000000000947
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：344 / 344
页数：1
相关论文
共 50 条
  • [21] SGLT-2 Inhibitors: Potential Novel Strategy to Prevent Congestive Heart Failure in Diabetes?
    Verbrugge F.H.
    Vangoitsenhoven R.
    Mullens W.
    Van der Schueren B.
    Mathieu C.
    Tang W.H.W.
    [J]. Current Cardiovascular Risk Reports, 2015, 9 (8)
  • [22] SGLT-2 inhibitors in heart failure: a new therapeutic avenue
    Muthiah Vaduganathan
    Javed Butler
    [J]. Nature Medicine, 2019, 25 : 1653 - 1654
  • [23] SGLT-2 Inhibitors - a Novel Treatment Option in Heart Failure
    Schuett, Katharina
    Berger, Martin
    Marx, Nikolaus
    [J]. AKTUELLE KARDIOLOGIE, 2021, 10 (04) : 297 - 301
  • [24] Loop diuretic use among patients with heart failure and type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors
    Weeda, Erin R.
    Cassarly, Christy
    Brinton, Daniel L.
    Shirley, David W.
    Simpson, Kit N.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (08) : 567 - 571
  • [25] The nephrological perspective on SGLT-2 inhibitors in type 1 diabetes
    Gillard, Pieter
    Schnell, Oliver
    Groop, Per-Henrik
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 170
  • [26] SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice
    Giaccari, Andrea
    Pontremoli, Roberto
    Filardi, Pasquale Perrone
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 351 : 66 - 70
  • [27] Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease
    Nevola, Riccardo
    Alfano, Maria
    Pafundi, Pia Clara
    Brin, Chiara
    Gragnano, Felice
    Calabro, Paolo
    Adinolfi, Luigi Elio
    Rinaldi, Luca
    Sasso, Ferdinando Carlo
    Caturano, Alfredo
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (03)
  • [28] Diuretic treatment of the patient with diabetes and heart failure. Role of SGLT2 inhibitors and similarities with carbonic anhydrase inhibitors
    Leon Jimenez, D.
    Gomez Huelgas, R.
    Fernandez Romero, A. J.
    Lopez Chozas, J. M.
    Perez de Isla, L.
    Miramontes Gonzalez, J. P.
    [J]. REVISTA CLINICA ESPANOLA, 2019, 219 (04): : 208 - 217
  • [29] Can SGLT-2 inhibitors resolve the heart failure burden of diabetes mellitus - Is it empaglifozin or the class?
    Tschoepe, Diethelm
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (07) : 1075 - 1076
  • [30] SGLT-2 Inhibitors Reduce Heart Failure-Related Hospitalization in Patients Without Diabetes
    Shaughnessy, Allen F.
    [J]. AMERICAN FAMILY PHYSICIAN, 2022, 106 (04) : 461 - 462
12345